Efficacy and safety of upadacitinib in patients with active ankylosing spondylitis (SELECT-AXIS 1): a multicentre, randomised, double-blind, placebo-controlled, phase 2/3 trial-Reference-Cited by-同舟云学术

Efficacy and safety of upadacitinib in patients with active ankylosing spondylitis (SELECT-AXIS 1): a multicentre, randomised, double-blind, placebo-controlled, phase 2/3 trial

Published:2019-12 Issue:10214 Volume:394 Page:2108-2117
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

van der Heijde Désirée,Song In-Ho,Pangan Aileen L,Deodhar Atul,van den Bosch Filip,Maksymowych Walter P,Kim Tae-Hwan,Kishimoto Mitsumasa,Everding Andrea,Sui Yunxia,Wang Xin,Chu Alvina D,Sieper Joachim

Funder

AbbVie

Publisher

Elsevier BV

Subject

General Medicine

Reference37 articles.

1. Spondyloarthritis;Dougados;Lancet,2011

2. Axial spondyloarthritis;Sieper;Lancet,2017

3. 2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis;van der Heijde;Ann Rheum Dis,2017

4. 2019 Update of the American College of Rheumatology/Spondylitis Association of America/Spondyloarthritis Research and Treatment Network recommendations for the treatment of ankylosing spondylitis and nonradiographic axial spondyloarthritis;Ward;Arthritis Care Res (Hoboken),2019

5. Secukinumab efficacy in anti-TNF-naive and anti-TNF-experienced subjects with active ankylosing spondylitis: results from the MEASURE 2 Study;Sieper;Ann Rheum Dis,2017

Cited by 266 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic inhibition of the JAK-STAT pathway in the treatment of inflammatory bowel disease;Cytokine & Growth Factor Reviews;2024-10

2. Nociplastic pain in axial spondyloarthritis and psoriatic arthritis: role of JAK kinases in immunopathology and therapeutic impact of JAK inhibitors;Expert Review of Clinical Immunology;2024-09-08

3. Newer Therapies in Rheumatology;Medical Clinics of North America;2024-09

4. Rotation or change of biotherapy after TNF blocker treatment failure for axial spondyloarthritis: the ROC-SpA study, a randomised controlled study protocol;BMJ Open;2024-09

5. Treatment strategies for Spondyloarthritis: Implementation of precision medicine – Or “one size fits all” concept?;Autoimmunity Reviews;2024-09